Subscribe

F/M Emerald Life Sciences Innovation ETF (LFSC)

USD45.19 -1.10 (-2.38%)
NASDAQ USD US Equity
NAV USD 32.18 +40.41% vs NAV as of 2025-10-31
AUM USD 74.65M
TER 0.54%
Yield (TTM)
Distribution Accumulating*
52-week range 24.22 – 47.38
Holdings 40
Issuer F/m

About this ETF

LFSC seeks to invest in innovative life sciences companies that are expected to create value and long-term growth. The actively managed fund relies on a specialized and experienced team to research complex life sciences companies. It invests in US equity securities identified to have growth potential that meet the criteria of technological advancement, market disruption, or artificial intelligence. The broad life science field includes biotechnology, pharmaceutical, medical diagnostics and devices, healthcare services and technologies, and synthetic biology. Stock selection employs an extensive 10-step research process that includes reviews of publicly available and third-party information, peer reviews, financial and valuation models, internal research, surveys, as well as interviews and contact with management, industry and medical professionals, supply chain, and collaboration within…

ISIN US74933W2219
Issuer F/m
Domicile US
Inception 2024-10-21
Asset class Equity

Price

Sector mix

No sector breakdown available for this fund.